General Information of the Compound
| Compound ID |
CP0225551
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine
872872-12-3
AKOS030605024
BDBM50179205
CHEMBL175596
CTK3C4931
DTXSID20468426
Indeno[1,2-c]pyrazol-3-amine, 1,4-dihydro-N-phenyl-
SCHEMBL4045943
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H13N3
|
||||||||||||||||||
| Molecular Weight |
247.301
|
||||||||||||||||||
| Canonical SMILES |
C1c2ccccc2-c2n[nH]c(Nc3ccccc3)c12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H13N3/c1-2-7-12(8-3-1)17-16-14-10-11-6-4-5-9-13(11)15(14)18-19-16/h1-9H,10H2,(H2,17,18,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
HXUODZKNCJWKGP-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound